Spain Owes $10 Billion on Health Products, Merck’s Strigini Says
Spain faces $6 billion in pharmaceutical debt and owes about $4 billion for medical devices, said Bruno Strigini, Merck & Co.’s president of Europe and Canada.
Industry representatives are in talks with the Spanish government over the debt, and international intervention may be needed to resolve the payment issues, Strigini said today at The Economist’s pharmaceutical conference in London.
“We are right in the middle of those discussions today, and I don’t see how we can get to a conclusion that satisfies without the help of an international institution,” he said.
To contact the reporter on this story: Naomi Kresge in Berlin at nkresge@bloomberg.net
To contact the editor responsible for this story: Kristen Hallam at khallam@bloomberg.net
Rate this Page